AIGH Capital Management LLC

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1835943 BALTIMORE, MD

Position in FENC

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$26,724,908

+$14,538,678 QoQ

Shares Held

2,486,038

+25.5% QoQ

Ownership

7.09%

of shares outstanding

% of Portfolio

2.42%

of 13F equity value

Holder Rank

of 104 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 75% Shared 25% None 0%

Healthcare · as of Jun 30, 2026

AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names. FENC ranks #1 (17.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FENC	Fennec Pharmaceuticals Inc. This page	2,486,038	$26,724,908
2	KYTX	Kyverna Therapeutics, Inc.	2,795,797	$24,910,550
3	ABEO	Abeona Therapeutics Inc.	2,987,000	$18,459,660
4	ARDX	Ardelyx, Inc.	3,200,000	$16,319,999
5	SPRB	Spruce Biosciences, Inc.	250,000	$13,500,000
6	VNDA	Vanda Pharmaceuticals Inc.	2,044,169	$12,510,313
7	PTHS	Pelthos Therapeutics Inc.	329,098	$9,300,309
8	PYPD	PolyPid Ltd.	1,504,741	$7,644,084

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,724,908	2,486,038	+25.5%	Shares	Other	2026-08-07
2026-03-31	$12,186,230	1,981,501	+25.3%	Shares	Other	2026-04-30
2025-12-31	$12,177,557	1,581,501	+132.1%	Shares	Other	2026-02-02
2025-09-30	$6,378,848	681,501	+50.6%	Shares	Other	2025-10-31
2025-06-30	$3,754,919	452,400	+25.3%	Shares	Other	2025-07-29
2025-03-31	$2,198,519	361,005	-36.7%	Shares	Other	2025-05-06
2024-03-31	$6,342,091	570,332	+73.2%	Shares	Other	2024-05-14
2023-12-31	$3,695,531	329,370	-11.8%	Shares	Other	2024-02-12
2023-09-30	$2,805,179	373,526	+6.9%	Shares	Other	2023-11-13
2023-06-30	$3,085,705	349,457	+115.5%	Shares	Other	2023-08-14
2023-03-31	$1,349,121	162,154	—	Shares	Other	2023-05-15
No filing history on record for this holder in this stock.